Hou Po

Magnolia officinalis Rehd. et Wils.

Also known as: Magnolia bark(English) 厚朴(Chinese)

Kōboku厚朴 コウボク(JP also admits Magnolia obovata) Hubak厚朴 후박 Hậu phác(source species Magnolia officinalis var. biloba) Hou P'o

Updated October 23, 2026 · Not yet clinically reviewed

Hou Po
Photo: Photo by David J. Stang, CC BY-SA 4.0, via Wikimedia Commons

Safety at a glance

Note

5 recorded drug interactions

Note

Contraindications or side effects are listed

No rule in our tables for this herb: pregnancy, breastfeeding, incompatible pairs (十八反 / 十九畏), herb–drug, dose ceiling. This is not a safety clearance.
Not graded —

No toxicity grade is recorded. Most herbs in the catalogue carry none.

Traditional Chinese Medicine

Category
transforming dampness
Temperature
Warm
Taste
Bitter,Pungent
Channels
Spleen,Stomach,Lung,Large Intestine

Functions

Dries Dampness and Transforms Phlegm; Descends Qi and Relieves Distension; Moves Qi and Resolves Stagnation; Calms Wheezing

Traditional uses

Hou Po (magnolia bark) is a warm, bitter-pungent herb that moves Qi, dries Dampness, and descends rebellious Qi in the Stomach and Lung. It is a primary herb for abdominal fullness, distension, and obstruction from Qi stagnation and Dampness in the middle burner. Its descending action also calms Lung Qi to relieve cough and wheezing with chest fullness. Because it moves and dries, it must be used cautiously in Yin deficiency and is contraindicated in pregnancy without careful formulation.

Western herbalism

Properties: carminative, antispasmodic, sedative

Pharmacological effects

  • Anti-emetic: Methanol extract of M. obovata bark (1 g/kg oral) was anti-emetic in frogs with copper sulphate-induced emesis; magnolol and honokiol were active at 20 mg/kg.
  • Muscle relaxation: Magnolol (100 mg/kg i.p., mice) gave strong central muscle relaxation for 2 h; higher doses of magnolol/honokiol abolished righting reflex; magnolol inhibited chicken extensor reflex (antagonized by strychnine); both inhibited K+ and Ca++ contraction of rat aorta.
  • Antiulcerative: Magnolol inhibited Shay pylorus-ligation and water-immersion stress ulcers, histamine-induced duodenal spasm, and stimulated gastric acid secretion in anesthetized rats.
  • Central inhibitory: Ether extract (i.p., mice) reduced spontaneous activity, antagonized methamphetamine/apomorphine excitation, produced slow-wave EEG and raised brain serotonin; magnolol and honokiol were the depressant principles.
  • Antimicrobial: Decoction active in vitro against S. aureus, Streptococcus hemolyticus, B. diphtheriae, B. subtilis, B. dysenteriae and skin fungi; prolonged survival of anthrax-infected guinea pigs; magnolol and honokiol bactericidal to Streptococcus mutans at 6.3 µg/ml, stronger than berberine.
  • Antiplatelet: Magnolol and honokiol inhibited collagen-induced rabbit platelet aggregation with IC50 1.9 x 10^-6 M, about three times more potent than aspirin.

Source: Zhu YP. Chinese Materia Medica: Chemistry, Pharmacology and Applications. Harwood Academic, 1998, p. 304.

Formulas using this herb

87 of 87 formulas

Botanical

Magnolia officinalis is a deciduous tree in the Magnoliaceae, endemic to mountainous regions of central and southern China, where it grows in mixed broadleaved forests between 300 and 1,500 m elevation. Mature specimens reach 15-25 m tall with a straight trunk, ascending branches and a broad, rounded crown. The bark is smooth and pale grey on young trees, becoming thicker, fissured and brownish with age, and is strongly aromatic when cut. The large, alternate leaves are obovate to elliptic, 20-45 cm long, leathery, dark green above and pale glaucous beneath, often clustered toward the branch tips. In early summer the tree bears solitary, fragrant, cup-shaped flowers 10-15 cm across, with 9-12 fleshy, creamy-white tepals. The aggregate fruit is a long, cylindrical, cone-like structure of follicles that split to release scarlet, fleshy-coated seeds. Cultivated trees are typically harvested for medicinal bark after 15-20 years.

Family
Magnoliaceae
Pharmaceutical name
Cortex Magnoliae Officinalis
Parts used
bark
Plant type
tree
Native region
Guizhou, Hubei, Hunan, Sichuan, Zhejiang

Constituents

Magnolol

Biphenolic neolignan · Principal neolignan of the stem and root bark; the Chinese Pharmacopoeia requires magnolol plus honokiol to total not less than 2.0% of the dried bark

Positively modulates synaptic and extrasynaptic GABA-A receptors, which underlies the anxiolytic and sleep-promoting activity attributed to the bark, and is anti-inflammatory, antimicrobial and antispasmodic in preclinical models.

This drug is the bark. The flower bud of the same species is a separate item of materia medica, Hou Po Hua, whose magnolol and honokiol content is roughly an order of magnitude lower; evidence generated on bark extracts should not be read across to it.

Honokiol

Biphenolic neolignan · Second major neolignan, assayed jointly with magnolol to the 2.0% Pharmacopoeia minimum

An isomer of magnolol that also potentiates GABA-A receptor currents and shows anti-inflammatory, neuroprotective and antitumour activity in preclinical work; it is the more studied of the pair for anticancer and neuroprotective endpoints.

beta-Eudesmol

Sesquiterpene alcohol · Major component of the bark essential oil, which itself is a minor fraction of the drug

A volatile sesquiterpene contributing to the aromatic, qi-moving character of the bark; reported to affect gastrointestinal motility and neuromuscular transmission in preclinical models.

Magnocurarine

Quaternary benzylisoquinoline alkaloid · Trace alkaloid of the bark; substantially higher in some other Magnolia and Manglietia species used as substitutes

Structurally related to tubocurarine and carries the same curare-like neuromuscular blocking liability, which is the basis of regulatory caution about magnolia bark in infants and small children.

Levels in authentic Magnolia officinalis bark are low, and the concern is greatest where a related species with higher magnocurarine content has been supplied in its place.

Magnoflorine

Aporphine alkaloid · Minor alkaloid of the bark

One of several minor isoquinoline-type alkaloids identified in the bark by HPLC-ESI-MSn alongside magnocurarine and tembetarine; not a target of Pharmacopoeia assay and not a principal contributor to the drug's recognised actions.

Drug interactions

Benzodiazepines, Z-drugs, alcohol and other CNS depressants

Moderate · Additive sedation, impaired psychomotor performance · Evidence level: Probable

Magnolol and honokiol are positive modulators at synaptic and extrasynaptic GABA-A receptors, the same target class as benzodiazepines and Z-drugs, so co-administration is expected to be additive. Human data are limited to small trials of proprietary bark extracts on stress and sleep endpoints, so the size of the effect at decoction doses is not quantified.

Clinical note: Warn patients taking hypnotics or sedating antihistamines about additive drowsiness, and about driving. The interaction is pharmacodynamic and dose-related; it is not a reason to withhold the herb but is a reason to start low.

QT-prolonging drugs

Moderate · Potential QT prolongation and arrhythmia risk · Evidence level: Possible

Both magnolol and honokiol block the hERG potassium channel in vitro, and their blockade is additive when the two are present together, as they always are in the bark. This is patch-clamp evidence in a heterologous expression system, not a clinical arrhythmia signal, and no case reports of torsades attributable to Hou Po are on record.

Clinical note: Take the concern seriously in patients already on QT-prolonging medication such as sotalol, amiodarone, methadone or macrolides, or with known long QT, hypokalaemia or hypomagnesaemia. For everyone else the in vitro finding does not warrant avoiding a standard course.

CYP1A2 and CYP2C substrates

Moderate · Altered plasma concentrations of substrate drugs · Evidence level: Possible

Honokiol and magnolol modulate rat hepatic CYP1A and CYP2C activity and change the pharmacokinetics of phenacetin and diclofenac in vivo, with the two neolignans acting differently from each other. The work is in rats; human interaction studies have not been done.

Clinical note: Watch for altered effect of theophylline, clozapine, warfarin, phenytoin and NSAIDs when a bark extract is used at concentrated doses over weeks. Species extrapolation is imperfect here, so monitoring the drug rather than avoiding the herb is the proportionate response.

Non-depolarising neuromuscular blocking agents

Theoretical · Potential potentiation of neuromuscular blockade · Evidence level: Theoretical

The bark contains magnocurarine, a quaternary benzylisoquinoline alkaloid structurally analogous to tubocurarine, and Health Canada has warned that magnolia bark contains tubocurarine-related substances capable of causing respiratory paralysis in animals. No human interaction with anaesthetic neuromuscular blockers has been reported, and magnocurarine content in authentic Magnolia officinalis bark is low.

Clinical note: Include Hou Po in the herbal history taken before general anaesthesia and stop it in the standard pre-operative window. The regulatory caution about infants and small children is the more practically relevant point for routine dispensing.

Hou Po Hua (Flos Magnoliae Officinalis, the flower bud of the same species)

Minor · Substitution reduces the delivered dose of the active neolignans · Evidence level: Established

Hou Po Hua is the dried flower bud of Magnolia officinalis and is a separate Pharmacopoeia drug with its own assay and a far lower magnolol and honokiol content than the bark, on the order of a tenth. Because the pinyin names differ by only one syllable and both derive from the same species, the two are occasionally conflated in supply and in reference databases.

Substituting the flower bud for the bark is not toxic, but it under-delivers the constituents the bark's evidence rests on, and the flower is traditionally regarded as a gentler drug for qi stagnation rather than an equivalent of the bark.

Clinical note: Confirm that a supplier's Hou Po is Cortex Magnoliae Officinalis and not Flos Magnoliae Officinalis, and do not read bark studies onto flower-bud products.

Dosage

FormAmountFrequencyNotes
decoction3–10 gDaily
中国药典 2020 【用法与用量】3~10g。 【性味与归经】苦、辛,温。归脾、胃、肺、大肠经。 — Chinese Pharmacopoeia 2020, quoted verbatim; route and cautions preserved. Replaces a cleared category-filler value.

Dui yao: classical pairings

Hou Po + Ban Xia半夏

Transforms phlegm and descends counterflow while moving qi and dispersing constraint, dissolving the phlegm-qi knot in the throat.

Plum-pit qi: sensation of something stuck in the throat that cannot be swallowed or coughed up.

Core pair of a classical formula — Ban Xia Hou Po Tang, Jin Gui Yao Lue (Zhang Zhongjing)

Hou Po + Cang Zhu苍术

Dries dampness and moves qi together, relieving the fullness and distention of dampness encumbering the spleen and stomach.

Epigastric and abdominal distention, no appetite, thick greasy tongue coating.

Core pair of a classical formula — Ping Wei San, Taiping Huimin Hejiju Fang

Hou Po + Huang Lian黄连

Clears heat and dries dampness while moving qi, resolving damp-heat obstructing the middle burner.

Damp-heat sudden turmoil disorder with vomiting and diarrhea.

Core pair of a classical formula — Lian Po Yin, Huo Luan Lun (Wang Shixiong)

Hou Po + Xiang Ru香薷

Releasing summer-cold from the exterior combines with transforming dampness and moving qi internally, addressing summertime cold invasion with dampness.

Summer: chills and fever without sweating plus abdominal fullness, nausea or diarrhea.

Core pair of a classical formula — Xiang Ru San, Tai Ping Hui Min He Ji Ju Fang

Hou Po + Xing Ren杏仁

Descend lung qi and transform phlegm to calm wheezing.

Wheezing in an exterior pattern or chronic wheezing with phlegm. Xing Ren is mildly toxic in overdose.

Core pair of a classical formula — Gui Zhi Jia Hou Po Xing Zi Tang, Shang Han Lun (Zhang Zhongjing)

Hou Po + Zhi Shi枳实

Move qi and break up stagnation in the stomach and intestines, relieving distention, fullness and constipation.

Abdominal fullness and pain with constipation from qi stagnation.

Core pair of a classical formula — Hou Po San Wu Tang, Jin Gui Yao Lue (Zhang Zhongjing)

Hou Po + Zi Su Zi紫苏子

Descends lung qi and transforms phlegm while moving qi and calming wheezing, addressing excess above with phlegm-qi counterflow.

Core pair of a classical formula — Su Zi Jiang Qi Tang, Tai Ping Hui Min He Ji Ju Fang

Evidence

Study design on record, not certainty of outcome.

Randomized controlled trial
2
In vitro / animal
3

Effects of Ban-Xia-Hou-Pu-Tang and Western medicine on patients with globus sensation: A randomized controlled trial

Yeh HF, Chu YS, Hwang SJ, Chen FP, Lu YT · Journal of the Chinese Medical Association · 2025 · RCT

Randomized controlled trial · Verified

Randomized controlled trial comparing Ban-Xia-Hou-Pu-Tang against Western medical management in patients with globus sensation, the classical plum-pit qi presentation for which this formula is the standard prescription.

Hou Po is one of five ingredients in the formula, so the trial supports the traditional indication but does not isolate the bark's contribution.

doi:10.1097/JCMA.0000000000001237

Effect of a proprietary Magnolia and Phellodendron extract on stress levels in healthy women: a pilot, double-blind, placebo-controlled clinical trial

Kalman DS, Feldman S, Feldman R, Schwartz HI, Krieger DR, Garrison R · Nutrition Journal · 2008 · RCT

Randomized controlled trial · Not yet verified

Pilot double-blind placebo-controlled trial of a proprietary Magnolia officinalis bark and Phellodendron amurense extract in premenopausal women reporting stress-related eating, showing improvement in transient anxiety measures over six weeks.

Small, pilot-scale, industry-linked, and testing a two-herb combination product rather than Hou Po alone; it is among the very few human trials of a magnolia bark extract and should be weighted accordingly.

doi:10.1186/1475-2891-7-11

hERG channel blockade and additive interactions of magnolol and honokiol from Magnolia species

Zhao W, Hao T, Lu H, Jiang C, Xu J, Zhang Z, Stalin A, Zhang X, Pan L, Xu J · Toxicology Letters · 2026 · in vitro

In vitro / animal · Not yet verified

Patch-clamp study finding that magnolol and honokiol each block the hERG potassium channel and that their effects are additive when combined, which matters because the bark always delivers both together.

In vitro only; it establishes a cardiac liability signal for the isolated neolignans rather than a clinical arrhythmia risk for the crude drug.

doi:10.1016/j.toxlet.2026.113152

Modulation of Rat Hepatic CYP1A and 2C Activity by Honokiol and Magnolol: Differential Effects on Phenacetin and Diclofenac Pharmacokinetics In Vivo

Kim SB, Kim KS, Ryu HM, Hong SH, Kim BK, Kim DD, Park JW, Yoon IS · Molecules · 2018 · animal

In vitro / animal · Verified

In rats, honokiol and magnolol altered hepatic CYP1A and CYP2C activity and changed the pharmacokinetics of the probe substrates phenacetin and diclofenac, with the two neolignans producing different effects.

This is the principal experimental basis for the CYP-mediated interaction caution; it has not been reproduced in humans.

doi:10.3390/molecules23061470

Studies on the Alkaloids of the Bark of Magnolia officinalis: Isolation and On-line Analysis by HPLC-ESI-MSn

Yan R, Wang W, Guo J, Liu H, Zhang J, Yang B · Molecules · 2013 · in vitro

In vitro / animal · Not yet verified

Analytical characterisation of the alkaloid fraction of Magnolia officinalis bark, identifying magnocurarine, magnoflorine, tembetarine and related isoquinoline alkaloids by HPLC-ESI-MSn.

Documents that the curare-like alkaloid is genuinely present in the bark, alongside the much better known neolignans.

doi:10.3390/molecules18077739

Safety

Contraindications

Its use is cautious in patients with qi deficiency and fluid consumption or pregnant women.

Source: Xi S, Gong Y. Essentials of Chinese Materia Medica and Medical Formulas. Academic Press/Elsevier, 2017, pp. 131–133.

Cultural and historical

Shen Nong Ben Cao Jing · Han dynasty, compiled c. 200 BCE to 200 CE

Lists Hou Po among the middle-grade drugs, for wind-cold with headache, cold and heat, and blockage and pain in the abdomen. The entry specifies the bark, which is the drug still assayed today.

Shang Han Lun (Treatise on Cold Damage), Zhang Zhongjing · Eastern Han dynasty, c. 200 to 210 CE

Hou Po is a component of Da Cheng Qi Tang and Hou Po San Wu Tang, where it is paired with Zhi Shi to descend qi and relieve abdominal fullness and distension. This is the origin of its standing indication for focal distension.

Jin Gui Yao Lue (Essential Prescriptions of the Golden Cabinet), Zhang Zhongjing · Eastern Han dynasty, c. 220 CE

Source of Ban Xia Hou Po Tang for the sensation of a piece of roasted meat lodged in the throat, the presentation later called plum-pit qi and the indication tested in modern globus-sensation trials.

Ming Yi Bie Lu (Miscellaneous Records of Famous Physicians) · Attributed to Tao Hongjing, c. 500 CE

Adds the warming and drying actions for cold in the stomach with vomiting and for phlegm and rheum, and notes the drug as acrid and warm, the character basis for its use in damp obstruction of the middle burner.

Ben Cao Gang Mu (Compendium of Materia Medica), Li Shizhen · Ming dynasty, 1578, printed 1596

Describes preparation of the bark by removing the coarse outer layer and processing with ginger juice to temper its dryness, the ginger-processed form still in general use. Li Shizhen also treats the flower bud separately from the bark.

References

  1. Poivre M, Duez P. Biological activity and toxicity of the Chinese herb Magnolia officinalis Rehder & E. Wilson (Houpo) and its constituents. Journal of Zhejiang University-SCIENCE B. 2017 doi:10.1631/jzus.B1600299
  2. Sarrica A, Kirika N, Romeo M, Salmona M, Diomede L. Safety and Toxicology of Magnolol and Honokiol. Planta Medica. 2018 doi:10.1055/a-0642-1966
  3. Luo H, Wu H, Yu X, Zhang X, Lu Y, Fan J, Tang L, Wang Z. A review of the phytochemistry and pharmacological activities of Magnoliae officinalis cortex. Journal of Ethnopharmacology. 2019 doi:10.1016/j.jep.2019.02.041
  4. Yuan Y, Zhou X, Wang Y, Wang Y, Teng X, Wang S. Cardiovascular Modulating Effects of Magnolol and Honokiol, Two Polyphenolic Compounds from Traditional Chinese Medicine-Magnolia Officinalis. Current Drug Targets. 2020 doi:10.2174/1389450120666191024175727

Look-alike names

© Verscienta Health — use subject to the API terms at https://verscienta.com/developers/api; educational reference, not medical advice